|Mr. Chung Yuen Huen||Founder, Chairman & CEO||N/A||N/A||1980|
|Mr. Darren Lui||Pres, Chief Bus. Officer & Exec. Director||N/A||N/A||1981|
|Ms. Sabrina Khan||Chief Financial Officer||N/A||N/A||1981|
|Dr. Siu-yan Ng||Chief Operating Officer||N/A||N/A||1981|
|Mr. Clark Cheng||Chief Medical Officer & Exec. Director||N/A||N/A||1980|
Aptorum Group Limited, a pharmaceutical company, develops and commercializes a range of therapeutic and diagnostic technologies to treat unmet medical needs. It focuses on developing various drug molecules and certain technologies for the treatment and diagnosis of human disease conditions in neurology, infectious diseases, gastroenterology, oncology, and other disease areas. The company also focuses on the development of surgical robotics and medical devices; and operating outpatient clinic. Aptorum Group Limited was incorporated in 2010 and is headquartered in Central, Hong Kong.
Aptorum Group Limited’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.